Mechanisms of Action and Targets for Actual and Future Antiplatelet Drugs

Author(s): Kathleen Freson, Chantal Thys, Christine Wittevrongel, Chris V. Geet

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 6 , Issue 6 , 2006


Become EABM
Become Reviewer
Call for Editor

Abstract:

Platelets are key players in arterial thrombosis and have become important targets in the primary and secondary prevention of atherothrombosis. Antiplatelet drugs are primarily directed against platelets and inhibit platelet activation by a number of different mechanisms. They are used for the prevention and treatment of thrombotic processes, especially in the arterial vascular system. Antiplatelet drugs in clinical use and experimental drugs are discussed.

Keywords: cyclooxygenase, GPIIb/IIIa antagonists, Ticlopidine, monoclonal antibody, Thrombin Receptors

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 6
ISSUE: 6
Year: 2006
Page: [719 - 726]
Pages: 8
DOI: 10.2174/138955706777435661
Price: $65

Article Metrics

PDF: 1